Field Trip Health Ltd

Company Profile

Field Trip Health Ltd had its IPO on 2021-07-29 under the ticker symbol REUN.

The company operates in the Healthcare sector and Biotechnology industry. Field Trip Health Ltd has a staff strength of 16 employees.

Stock update

Shares of Field Trip Health Ltd opened at $1.12 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.12 - $1.12, and closed at $1.12.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Field Trip Health Ltd have increased by +0.9%.

Field Trip Health Ltd's Key Ratios

Field Trip Health Ltd has a market cap of $13.01 million, indicating a price to book ratio of 0.4939 and a price to sales ratio of 2.8033.

In the last 12-months Field Trip Health Ltd’s revenue was $4.86 million with a gross profit of $-4290107 and an EBITDA of $-25673520. The EBITDA ratio measures Field Trip Health Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Field Trip Health Ltd’s operating margin was 0% while its return on assets stood at -26.51% with a return of equity of -86.35%.

In Q1, Field Trip Health Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Field Trip Health Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.51 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Field Trip Health Ltd’s profitability.

Field Trip Health Ltd stock is trading at a EV to sales ratio of 0.1207 and a EV to EBITDA ratio of 0.2175. Its price to sales ratio in the trailing 12-months stood at 2.8033.

Field Trip Health Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$29.74 million

Total Liabilities

$8.44 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Field Trip Health Ltd ended 2024 with $29.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $29.74 million while shareholder equity stood at $21.30 million.

Field Trip Health Ltd ended 2024 with $0 in deferred long-term liabilities, $8.44 million in other current liabilities, 107273342.00 in common stock, $-91483109.00 in retained earnings and $0 in goodwill. Its cash balance stood at $27.20 million and cash and short-term investments were $27.20 million. The company’s total short-term debt was $3,367,910 while long-term debt stood at $0.

Field Trip Health Ltd’s total current assets stands at $29.68 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $539927.00 compared to accounts payable of $0 and inventory worth $516755.00.

In 2024, Field Trip Health Ltd's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Field Trip Health Ltd paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.12

52-Week High

$3.1045

52-Week Low

$0.6303

Analyst Target Price

$17.15

Field Trip Health Ltd stock is currently trading at $1.12 per share. It touched a 52-week high of $3.1045 and a 52-week low of $3.1045. Analysts tracking the stock have a 12-month average target price of $17.15.

Its 50-day moving average was $1.07 and 200-day moving average was $1.1 The short ratio stood at 1.92 indicating a short percent outstanding of 0%.

Around 3438.8% of the company’s stock are held by insiders while 5065.8% are held by institutions.